Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-12 Purchase(A) | 2022-10-18 6:20 pm | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 38,500 | $2.0363 | $78,397 | 743,867 (Indirect Direct) | View |
| 2020-11-06 Purchase | 2020-11-10 3:48 pm | Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner | 195,500 | $0.20342 | $39,769 | 20,785,492 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-26 Option Award | 2023-10-30 12:30 pm | 2023-10-26 2028-10-26 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 30,000 | $0 | 926,293 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 5:00 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 21,900 | $1.988 | 1,011,204 (Indirect) | View |
| 2022-10-13 Option Award | 2022-10-13 5:00 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 16,600 | $2.1 | 1,011,204 (Indirect) | View |
| 2022-08-29 Option Award | 2022-08-29 5:18 pm | 2022-08-29 2027-08-29 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 30,000 | $0 | 756,792 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-02 1:58 pm | 2021-09-01 2026-09-01 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 15,000 | $0 | 655,791 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-09 12:57 pm | 2021-06-08 2026-06-08 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 23,334 | $0 | 584,790 (Direct) | View |
| 2021-05-07 Other | 2021-06-09 12:48 pm | 2020-04-23 2025-04-23 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 23,334 | $0 | 614,791 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-27 5:13 pm | 2021-04-26 2026-04-26 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO 10% Owner | 26,000 | $0 | 582,124 (Direct) | View |
| 2020-05-06 Option Award | 2020-06-04 5:16 pm | 2020-05-06 2025-05-06 | Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner | 200,000 | $0 | 14,308,148 (Indirect) | View |
| 2020-05-06 Option Award | 2020-05-08 7:05 pm | N/A N/A | Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner | 200,000 | $0.23 | 20,189,992 (Indirect) | View |
| 2020-04-23 Option Award | 2020-04-23 1:30 pm | 2020-04-23 2025-04-23 | Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER Chief Executive Officer 10% Owner | 700,000 | $0 | 13,908,148 (Direct) | View |
| 2020-03-23 Other | 2020-03-24 2:34 pm | 2018-05-31 2023-05-31 | Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER Chief Executive Officer 10% Owner | 700,000 | $0 | 13,908,148 (Direct) | View |